Patient concerns regarding chronic hepatitis C infections

G Y Minuk1, A Gutkin, S G Wong

  • 1Section of Hepatology, University of Manitoba, Winnipeg, Manitoba, Canada. gminuk@cc.umanitoba.ca

Insights

Patients with chronic hepatitis C virus (HCV) infection have concerns beyond transmission, including disease progression and treatment side effects. Effective counselling must address these broader patient worries for better care.

Area of Science:

  • Hepatology
  • Public Health
  • Patient Care

Background:

  • Hepatitis C virus (HCV) infection counselling often focuses narrowly on transmission risks.
  • This limited scope may not address the full spectrum of patient concerns.

Purpose of the Study:

  • To identify and document the primary concerns of patients newly diagnosed with and those in follow-up for chronic HCV infection.
  • To inform and enhance current counselling strategies and content for HCV patients.

Main Methods:

  • Surveyed 70 newly diagnosed and 115 follow-up chronic HCV patients.
  • Collected 'volunteered concerns' via open-ended questions.
  • Gathered 'prioritized concerns' by having patients rank a list of seven potential issues.

Main Results:

  • Newly diagnosed patients' top concerns included disease progression, premature death, and infecting family.
  • Follow-up patients shared similar concerns.
  • Concerns remained consistent across various demographics and viral acquisition methods.

Conclusions:

  • Current HCV counselling, focused solely on transmission, fails to address patients' most significant concerns.
  • Counselling strategies need expansion to include disease progression, treatment effects, and psychosocial impacts.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...